Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Antonelli

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Is it possible to identify patients with inflammatory bowel disease who are at risk for cytomegalovirus infection?Gabrio Bassotti, Elisabetta Antonelli
Internal and Emergency Medicine|February 2, 2026
Repurposing metformin: another possible bullet to target cheaply ulcerative colitisElisabetta Antonelli, Gabrio Bassotti
Current Topics in Medicinal Chemistry|June 25, 2005
Dual COX-inhibitors: the answer is NO?Stefano Fiorucci, Elisabetta Antonelli
Inflammation & Allergy Drug Targets|April 15, 2006
NO-NSAIDs: from inflammatory mediators to clinical readoutsStefano Fiorucci, Elisabetta Antonelli
Journal of Clinical Medicine|August 14, 2025
Constipation in Ulcerative Colitis: An Underestimated ProblemGabrio Bassotti, Sara Bologna, Elisabetta Antonelli
Journal of Clinical Gastroenterology|August 3, 2019
Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative ColitisElisabetta Antonelli, Gabriele Torti, Gabrio Bassotti
World Journal of Gastroenterology|January 2, 2019
Novel oral-targeted therapies for mucosal healing in ulcerative colitisElisabetta Antonelli, Vincenzo Villanacci, Gabrio Bassotti
Endoscopy|August 1, 2015
Assessing mucosal healing in ulcerative colitis: the simpler, the better…Vincenzo Villanacci, Elisabetta Antonelli, Marianna Salemme, et al.
Metabolites|April 27, 2026
Back to the Future: Repurposing Metformin, a Metabolically Active Drug, to Treat Mild-to-Moderate Ulcerative ColitisElisabetta Antonelli, Alessandra Dell'Era, Giovanni Maconi, et al.
Cardiovascular Drug Reviews|June 5, 2004
Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current statusStefano Fiorucci, Elisabetta Antonelli, Paola Tocchetti, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Is it possible to identify patients with inflammatory bowel disease who are at risk for cytomegalovirus infection?Gabrio Bassotti, Elisabetta Antonelli
Internal and Emergency Medicine|February 2, 2026
Repurposing metformin: another possible bullet to target cheaply ulcerative colitisElisabetta Antonelli, Gabrio Bassotti
Current Topics in Medicinal Chemistry|June 25, 2005
Dual COX-inhibitors: the answer is NO?Stefano Fiorucci, Elisabetta Antonelli
Inflammation & Allergy Drug Targets|April 15, 2006
NO-NSAIDs: from inflammatory mediators to clinical readoutsStefano Fiorucci, Elisabetta Antonelli
Journal of Clinical Medicine|August 14, 2025
Constipation in Ulcerative Colitis: An Underestimated ProblemGabrio Bassotti, Sara Bologna, Elisabetta Antonelli
Journal of Clinical Gastroenterology|August 3, 2019
Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative ColitisElisabetta Antonelli, Gabriele Torti, Gabrio Bassotti
World Journal of Gastroenterology|January 2, 2019
Novel oral-targeted therapies for mucosal healing in ulcerative colitisElisabetta Antonelli, Vincenzo Villanacci, Gabrio Bassotti
Endoscopy|August 1, 2015
Assessing mucosal healing in ulcerative colitis: the simpler, the better…Vincenzo Villanacci, Elisabetta Antonelli, Marianna Salemme, et al.
Metabolites|April 27, 2026
Back to the Future: Repurposing Metformin, a Metabolically Active Drug, to Treat Mild-to-Moderate Ulcerative ColitisElisabetta Antonelli, Alessandra Dell'Era, Giovanni Maconi, et al.
Cardiovascular Drug Reviews|June 5, 2004
Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current statusStefano Fiorucci, Elisabetta Antonelli, Paola Tocchetti, et al.
Pageof 7